MSD BELGIUM
La probabilité de faillite calculée de MSD BELGIUM sur 12 mois est de 0,7% (faible). Les comptes annuels de 2023 montrent des capitaux propres de €53,38M et un résultat net de €15,50M. L'entreprise est active depuis 1969 et le Moniteur belge ne contient aucun signal d'insolvabilité ou d'avertissement.
| Capitaux propres | €53,38M |
| Résultat net | €15,50M |
| Effectif (ETP) | 151 |
| Active | 56 ans |
Profil exceptionnel, solide sur presque tous les axes.
Les 5 axes sont calculés sur des données lues par Checked.
Estimation statistique fondée sur des sources publiques, pas un conseil de crédit ni une constatation. Comment calculons-nous cela ?
Le détail complet du score, son historique par exercice et la limite de crédit indicative se débloquent à partir de Kantoor S.
Voir les plans →| Exercice | 2023 |
|---|---|
| Dépôt | volledig |
| Chiffre d'affaires | €567,48M |
| EBITDA | €19,99M |
| Résultat net | €15,50M |
| Cash-flow | €15,63M |
| Frais de personnel | €25,23M |
| Impôts sur le résultat | €5,44M |
| Dividendes | €0 |
| Total actif | €156,13M |
| Capitaux propres | €53,38M |
| Dettes | €102,75M |
| dont ≤ 1 an | €102,75M |
| dont > 1 an | - |
| Fonds de roulement | €52,98M |
| Employés (ETP) | 151,0 |
| 2023 | |
|---|---|
| Current ratio | 1,52 |
| Quick ratio | 1,52 |
| Ratio fonds de roulement | 33,9% |
| Solvabilité | 34,2% |
| Debt / equity | 1,92 |
| Endettement à long terme | - |
| Interest coverage | 202,63 |
| Rentabilité brute | 56,3% |
| Rentabilité nette | 2,7% |
| ROA | 9,9% |
| ROE | 29,0% |
| Marge EBITDA | 3,5% |
| Crédit clients (DSO) | 71d |
| Crédit fournisseurs (DPO) | 71d |
| Rotation des stocks | - |
| Jours de stock (DSI) | - |
| Poste | Code | 2023 |
|---|---|---|
| Bilan, Actif | ||
| TOTAL DE L'ACTIF | 20/58 | €156,13M |
| Actifs immobilisés | 21/28 | €401k |
| Immobilisations incorporelles | 21 | €396k |
| Immobilisations corporelles | 22/27 | €0 |
| Immobilisations financières | 28 | €4k |
| Actifs circulants | 29/58 | €155,73M |
| Créances à un an au plus | 40/41 | €155,73M |
| Valeurs disponibles | 54/58 | €4k |
| Bilan, Passif | ||
| TOTAL DU PASSIF | 10/49 | €156,13M |
| Capitaux propres | 10/15 | €53,38M |
| Apport / capital | 10/11 | €10,94M |
| Réserves | 13 | €396k |
| Bénéfice (perte) reporté(e) | 14 | €42,05M |
| Dettes | 17/49 | €102,75M |
| Dettes à un an au plus | 42/48 | €102,75M |
| Dettes commerciales à un an au plus | 44 | €48,19M |
| Compte de résultats | ||
| Chiffre d'affaires | 70 | €567,48M |
| Résultat d'exploitation | 9901 | €19,86M |
| Produits financiers | 75 | €1,18M |
| Charges financières | 65 | €99k |
| Résultat avant impôts | 9903 | €20,94M |
| Impôts sur le résultat | 67/77 | €5,44M |
| Résultat de l'exercice | 9904 | €15,50M |
| Résultat à affecter | 9905 | €15,63M |
-
Actif01-12-2024 → auj.
-
Actif02-05-2023 → auj.
-
Actif01-06-2021 → auj.
Historique, non confirmé récemment (7)
-
Non confirmé récemmentdernière confirmation dans un acte de 2011
-
Non confirmé récemmentdernière confirmation dans un acte de 2011
-
Non confirmé récemmentdernière confirmation dans un acte de 2007
-
Non confirmé récemmentdernière confirmation dans un acte de 2007
-
Non confirmé récemmentdernière confirmation dans un acte de 2007
-
Non confirmé récemmentdernière confirmation dans un acte de 2006
2 événements
- 26-07-2006 Mandat renouvelé· Administrateur
- 15-11-2004 Nommé· Administrateur
-
Non confirmé récemmentdernière confirmation dans un acte de 2005
Anciens dirigeants (23)
-
Ancien01-06-2021 → 01-12-2024
2 événements
- 01-12-2024 Démission· Administrateur
- 01-06-2021 Nommé· Administrateur
-
Ancien01-03-2019 → 02-05-2023
2 événements
- 02-05-2023 Démission· Administrateur
- 01-03-2019 Nommé· Gérant
-
Ancien07-10-2019 → 01-06-2021
2 événements
- 01-06-2021 Démission· Administrateur
- 07-10-2019 Nommé· Gérant
-
Ancien01-05-2020 → 01-06-2021
2 événements
- 01-06-2021 Démission· Administrateur
- 01-05-2020 Nommé· Administrateur
-
Ancien01-09-2017 → 01-05-2020
2 événements
- 01-05-2020 Démission· Administrateur
- 01-09-2017 Nommé· Gérant
-
Ancien01-05-2011 → 07-10-2019
2 événements
- 07-10-2019 Démission· Gérant
- 01-05-2011 Nommé· Niet statutair zaakvoerder
-
Ancien15-09-2016 → 01-03-2019
2 événements
- 01-03-2019 Démission· Gérant
- 15-09-2016 Nommé· Gérant
-
Ancien- → 01-09-2017
-
Ancien01-04-2013 → 15-09-2016
2 événements
- 15-09-2016 Démission· Gérant
- 01-04-2013 Nommé· Gérant
-
Ancien01-09-2011 → 30-11-2012
2 événements
- 30-11-2012 Démission· Gérant
- 01-09-2011 Nommé· Gérant
-
Ancien- → 11-11-2011
-
Ancien04-11-2009 → 01-09-2011
4 événements
- 01-09-2011 Démission· Gérant
- 01-05-2011 Nommé· Niet statutair zaakvoerder
- 04-11-2009 Nommé· President
- 04-11-2009 Nommé· Directeur generaal
-
Ancien26-07-2006 → 01-05-2011
2 événements
- 01-05-2011 Démission· Administrateur
- 26-07-2006 Nommé· Administrateur
-
Ancien15-05-2008 → 01-05-2011
2 événements
- 01-05-2011 Démission· Administrateur
- 15-05-2008 Nommé· Administrateur
-
Ancien20-09-2004 → 04-11-2009
3 événements
- 04-11-2009 Démission· Directeur generaal
- 04-11-2009 Démission· President
- 20-09-2004 Nommé· Directeur generaal
-
Ancien19-05-2008 → 02-07-2009
2 événements
- 02-07-2009 Démission· Administrateur
- 19-05-2008 Nommé· Administrateur
-
Ancien- → 30-05-2008
-
Ancien15-11-2004 → 15-05-2008
3 événements
- 15-05-2008 Démission· Administrateur
- 26-07-2006 Mandat renouvelé· Administrateur
- 15-11-2004 Nommé· Administrateur
-
Ancien17-12-2003 → 15-11-2004
3 événements
- 15-11-2004 Démission· Administrateur
- 20-09-2004 Démission· Afgevaardigde bestuurder
- 17-12-2003 Nommé· Administrateur
-
Ancien17-12-2003 → 15-11-2004
2 événements
- 15-11-2004 Démission· Administrateur
- 17-12-2003 Nommé· Administrateur
-
Ancien08-04-2004 → 15-11-2004
3 événements
- 15-11-2004 Démission· Administrateur
- 08-04-2004 Nommé· Administrateur
- 17-12-2003 Démission· Administrateur
-
Ancien- → 08-04-2004
-
Ancien- → 17-12-2003
| NACE primaire | Commerce de gros de produits pharmaceutiques et médicaux(46460) |
| Forme juridique | SRL(610) |
| Date de constitution | 23-10-1969 |
| Status | Actif |
| Code postal | 1170 |
Chaque bande indique sur quoi repose l'affirmation. Un siège d'administrateur est une influence sur la gestion, pas une propriété. Les mandats judiciaires (curateur, administrateur provisoire) et de liquidation ne relient pas des entreprises et ne figurent donc pas ici ; ils relèvent de Dirigeants & mandats.
Parcelles liées à cette entreprise via ses adresses BCE (siège, unités d'établissement, succursales), croisées avec le plan parcellaire cadastral. Ceci montre où l'entreprise est active, pas un registre de propriété.
| Parcelle (capakey) | Région | Superficie | Bâtiments | Hauteur / ét. |
|---|---|---|---|---|
| 21652E0905/00H000 | Bruxelles | 8,3 ha | 1 · 1,3 ha | 51,0 m · 3 ét. |
Une seule chronologie de tout ce qui est arrivé à cette entreprise, publications, événements d'insolvabilité et de cycle de vie, changements administratifs et comptes annuels déposés.
24-09-2025 1 administrateur nommé, 1 démissionnaire
- Arnaud Gain, Commissaris
- Didier Delanoye, Commissaris
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Arnaud Gain",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Didier Delanoye",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium"
}
}22-07-2025 Board meeting · Statute amendment · General meeting · Officer appointment
- Publication: 22/07/2025 · Algemene Vereniging van de Geneesmiddelenindustrie
- Filing: 11/07/2025 · Algemene Vereniging van de Geneesmiddelenindustrie
- Board meeting: 23/04/2025 · Algemene Vereniging van de Geneesmiddelenindustrie
- Statute amendment: wijziging delegatiereglement dagelijks bestuur · Algemene Vereniging van de Geneesmiddelenindustrie
- General meeting: 11/06/2025 · Algemene Vereniging van de Geneesmiddelenindustrie
- Officer appointment: role: bestuurder, start_date: 2025-06-11 · Almirall N.V.
- Officer appointment: role: bestuurder, start_date: 2025-06-11 · Novo Nordisk Pharma N.V.
- Officer appointment: role: bestuurder, start_date: 2025-06-11 · Takeda Belgium N.V.
- Officer reappointment: role: bestuurder, start_date: 2025-06-11 · Amgen N.V.
- Officer reappointment: role: bestuurder, start_date: 2025-06-11 · MSD Belgium N.V.
- Officer reappointment: role: bestuurder, start_date: 2025-06-11 · Roche N.V.
- Officer reappointment: role: bestuurder, start_date: 2025-06-11 · UCB Pharma N.V.
- Officer resignation: role: bestuurder, end_date: 2025-06-11 · Vertex Pharmaceuticals (Netherlands) BV
- Permanent representative: start_date: 16/05/2025 · Paul Lacante
- Permanent representative · Gregory Paton
- Permanent representative · Axel De Muyt
- Permanent representative · Bruno Rabilier
Détails techniques
{
"facts": [
{
"date": "2025-07-22",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad -22/07/2025 - Annexes du Moniteur belge",
"value": "22/07/2025",
"object": null,
"subject": "e1"
},
{
"date": "2025-07-11",
"type": "filing",
"quote": "neergelegd/ontvangen op 114 JULI 2025",
"value": "11/07/2025",
"object": null,
"subject": "e1"
},
{
"date": "2025-04-23",
"type": "board_meeting",
"quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 23 APRIL 2025",
"value": "23/04/2025",
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "Onderwerp akte: Benoeming bestuurders - wijziging delegatiereglement dagelijks bestuur",
"value": "wijziging delegatiereglement dagelijks bestuur",
"object": null,
"subject": "e1"
},
{
"date": "2025-06-11",
"type": "general_meeting",
"quote": "GEWONE ALGEMENE VERGADERING VAN 11 JUNI 2025",
"value": "11/06/2025",
"object": null,
"subject": "e1"
},
{
"date": "2025-06-11",
"type": "officer_appointment",
"quote": "Benoeming van: Almirall N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e2",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_appointment",
"quote": "Benoeming van: Novo Nordisk Pharma N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e3",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_appointment",
"quote": "Benoeming van: Takeda Belgium N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e4",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 1. Amgen N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e5",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 2. MSD Belgium N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e6",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 3. Roche N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e7",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 4. UCB Pharma N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e8",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"type": "officer_resignation",
"quote": "Ontslag van: 1. Vertex Pharmaceuticals (Netherlands) BV",
"value": {
"role": "bestuurder",
"end_date": "2025-06-11"
},
"object": null,
"subject": "e9",
"_value_raw": {
"role": "bestuurder",
"reason": "ontslag",
"end_date": "11/06/2025"
}
},
{
"date": "2025-05-16",
"type": "permanent_representative",
"quote": "Bristol-Myers Squibb Belgium N.V. ... heeft als nieuwe vaste vertegenwoordiger vanaf 16/05/2025 de heer Paul Lacante",
"value": {
"start_date": "16/05/2025"
},
"object": "e10",
"subject": "e11"
},
{
"type": "permanent_representative",
"quote": "Almirall N.V. ... heeft als vaste vertegenwoordiger de heer Gregory Paton",
"value": {},
"object": "e2",
"subject": "e13"
},
{
"type": "permanent_representative",
"quote": "Novo Nordisk Pharma N.V. ... heeft als vaste vertegenwoordiger de heer Axel De Muyt",
"value": {},
"object": "e3",
"subject": "e14"
},
{
"type": "permanent_representative",
"quote": "Takeda Belgium N.V. ... heeft als vaste vertegenwoordiger de heer Bruno Rabilier",
"value": {},
"object": "e4",
"subject": "e15"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 9714,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0407.622.902",
"kind": "company",
"name": "Algemene Vereniging van de Geneesmiddelenindustrie",
"attrs": {
"seat": "Kantersteen 47, 1000 Brussel",
"legal_form": "Vereniging zonder Winstoogmerk",
"short_name": "AVGI"
}
},
{
"id": "e2",
"kbo": "0403.090.131",
"kind": "company",
"name": "Almirall N.V.",
"attrs": {
"seat": "Lenneke Marelaan 4, 1932 Sint-Stevens-Woluwe"
}
},
{
"id": "e3",
"kbo": "0414.695.586",
"kind": "company",
"name": "Novo Nordisk Pharma N.V.",
"attrs": {
"seat": "Alfons Gossetlaan 32E/202, 1702 Groot-Bijgaarden"
}
},
{
"id": "e4",
"kbo": "0403.054.202",
"kind": "company",
"name": "Takeda Belgium N.V.",
"attrs": {
"seat": "Leonardo Da Vincilaan 7, 1930 Zaventem"
}
},
{
"id": "e5",
"kbo": "0439.652.401",
"kind": "company",
"name": "Amgen N.V.",
"attrs": {
"seat": "Telecomlaan 5-7, 1831 Diegem"
}
},
{
"id": "e6",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD Belgium N.V.",
"attrs": {
"seat": "Vorstlaan 25, 1170 Watermaal-Bosvoorde"
}
},
{
"id": "e7",
"kbo": "0403.088.151",
"kind": "company",
"name": "Roche N.V.",
"attrs": {
"seat": "Dantestraat 75, 1070 Anderlecht"
}
},
{
"id": "e8",
"kbo": "0403.096.168",
"kind": "company",
"name": "UCB Pharma N.V.",
"attrs": {
"seat": "Researchdreef 60, 1070 Anderlecht"
}
},
{
"id": "e9",
"kbo": "0666.408.905",
"kind": "company",
"name": "Vertex Pharmaceuticals (Netherlands) BV",
"attrs": {
"seat": "Leidsevaart 20, NL - 2013 HA Haarlem"
}
},
{
"id": "e10",
"kbo": "0403.075.184",
"kind": "company",
"name": "Bristol-Myers Squibb Belgium N.V.",
"attrs": {}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "Paul Lacante",
"attrs": {}
},
{
"id": "e12",
"kbo": null,
"kind": "person",
"name": "Sally McNab",
"attrs": {}
},
{
"id": "e13",
"kbo": null,
"kind": "person",
"name": "Gregory Paton",
"attrs": {}
},
{
"id": "e14",
"kbo": null,
"kind": "person",
"name": "Axel De Muyt",
"attrs": {}
},
{
"id": "e15",
"kbo": null,
"kind": "person",
"name": "Bruno Rabilier",
"attrs": {}
},
{
"id": "e16",
"kbo": null,
"kind": "company",
"name": "Facing BV",
"attrs": {}
},
{
"id": "e17",
"kbo": null,
"kind": "person",
"name": "Caroline Ven",
"attrs": {}
}
]
}28-11-2024 1 administrateur nommé, 1 démissionnaire
- Ciar Harbord, Bestuurder
- Rietja Hart, Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Rietja Hart",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Ciar Harbord",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium"
}
}08-07-2024 Didier Delanoye nommé commissaire
- Didier Delanoye, Commissaris
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Didier Delanoye",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium"
}
}21-06-2024 Permanent representative
- Publication: 21/06/2024 · Algemene Vereniging van de Geneesmiddelenindustrie
- Filing: 13/06/2024 · Algemene Vereniging van de Geneesmiddelenindustrie
- Permanent representative: start_date: 02/05/2023 · Katrien De Vos
- Permanent representative: end_date: 02/05/2023 · Brecht Vanneste
Détails techniques
{
"facts": [
{
"date": "2024-06-21",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 21/06/2024",
"value": "21/06/2024",
"object": null,
"subject": "e1"
},
{
"date": "2024-06-13",
"type": "filing",
"quote": "neergelegd/ontvangen op 13 JUNI 2024",
"value": "13/06/2024",
"object": null,
"subject": "e1"
},
{
"date": "2023-05-02",
"type": "permanent_representative",
"quote": "MSD Belgium B.V. (BE 0406.820.770) heeft als nieuwe vaste vertegenwoordiger vanaf 02/05/2023 mevrouw Katrien De Vos",
"value": {
"start_date": "02/05/2023"
},
"object": "e2",
"subject": "e3"
},
{
"type": "permanent_representative",
"quote": "in opvolging van de heer Brecht Vanneste",
"value": {
"revoked": true,
"end_date": "02/05/2023"
},
"object": "e2",
"status": "revoked",
"subject": "e4"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 926,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0407.622.902",
"kind": "company",
"name": "Algemene Vereniging van de Geneesmiddelenindustrie",
"attrs": {
"seat": "Terhulpsesteenweg 166, 1170 Brussel",
"legal_form": "Vereniging zonder Winstoogmerk",
"short_name": "AVGI"
}
},
{
"id": "e2",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD Belgium B.V.",
"attrs": {}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Katrien De Vos",
"attrs": {}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Brecht Vanneste",
"attrs": {}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Caroline Ven",
"attrs": {}
}
]
}21-06-2024 Act object · Permanent representative
- Publication: 21/06/2024
- Filing: 13/06/2024
- Act object: Nouveau représentant permanent d'un administrateur
- Permanent representative: replaces: e3, start_date: 02/05/2023 · Katrien De Vos
Détails techniques
{
"facts": [
{
"date": "2024-06-21",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 21/06/2024",
"value": "21/06/2024",
"object": null,
"subject": null
},
{
"date": "2024-06-13",
"type": "filing",
"quote": "neergelegd/ontvangen o\u0440 13 JUNI 2024",
"value": "13/06/2024",
"object": null,
"subject": null
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte: Nouveau repr\u00E9sentant permanent d\u0027un adm\u00EDnistrateur",
"value": "Nouveau repr\u00E9sentant permanent d\u0027un administrateur",
"object": null,
"subject": null
},
{
"date": "2023-05-02",
"type": "permanent_representative",
"quote": "MSD Belgium SRL (BE 0406.820.770) a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 02/05/2023 Madame Katrien De Vos, succ\u00E9dant \u00E0 Monsieur Brecht Vanneste.",
"value": {
"replaces": "e3",
"start_date": "02/05/2023"
},
"object": "e1",
"subject": "e2"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 905,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD Belgium SRL",
"attrs": {
"legal_form": "SRL"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Katrien De Vos",
"attrs": {}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Brecht Vanneste",
"attrs": {}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Caroline Ven",
"attrs": {}
}
]
}29-06-2023 1 administrateur nommé, 1 démissionnaire
- Katrien De Vos, Bestuurder
- Brecht Vanneste, Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Brecht Vanneste",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Katrien De Vos",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium"
}
}17-04-2023 Transfert du siège social de Sint-Lambrechts-Woluwe à Watermaal-Bosvoorde
- Lynxbinnenhof 5, 1200 Sint-Lambrechts-Woluwe (Brussel) → Vorstlaan 25, 1170 Watermaal-Bosvoorde (Brussel)
Détails techniques
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Vorstlaan 25, 1170 Watermaal-Bosvoorde (Brussel)",
"city": "Watermaal-Bosvoorde",
"region": "brussels_hoofdstedelijk_gewest",
"street": "Vorstlaan",
"country": "BE",
"postcode": "1170",
"box_number": null,
"street_number": "25",
"locality_suffix": "(Brussel)"
},
"old_address": {
"raw": "Lynxbinnenhof 5, 1200 Sint-Lambrechts-Woluwe (Brussel)",
"city": "Sint-Lambrechts-Woluwe",
"region": "brussels_hoofdstedelijk_gewest",
"street": "Lynxbinnenhof",
"country": "BE",
"postcode": "1200",
"box_number": null,
"street_number": "5",
"locality_suffix": "(Brussel)"
},
"effective_date": "2023-05-02",
"evidence_quote": "De bestuurders besluiter om de zetel van de Vennootschap te verplaatsen naar Vorstlaan 25, 1170 Watermaal-Bosvoorde (Brussel), met ingang vanaf 2 mei 2023.",
"region_changed": false,
"is_statute_change": false,
"nationality_change": false,
"old_address_source": "act_body",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "absolute",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": "Richard Liu",
"firm_city": null,
"firm_name": null,
"office_city": "Brussel",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2023-04-17",
"filing_date": "2023-04-06",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "enige_bestuurder",
"date": "2023-03-30",
"unanimous": true
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Richard Liu",
"org_rep_person_name": null,
"person_role_at_subject": "Lasthebber"
},
"co_filed_documents": [
"Uittreksel uit de eenparige schriftelijke besluiten van de bestuurders dd. 30 maart 2023",
"Bijzondere volmacht aan J\u00E9r\u00F4me Vermeylen, Richard Liu, Evrard de Lhoneux, Jef Sprengers en enige andere advocaat van ALTIUS CVBA"
]
}09-11-2022 Changement au sein de l'organe d'administration
Détails techniques
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium"
}
}03-08-2021 PwC Bedrijfsrevisoren nommé commissaire
- PwC Bedrijfsrevisoren, Commissaris
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "PwC Bedrijfsrevisoren",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD BELGIUM"
}
}11-06-2021 2 administrateurs nommés, 2 démissionnaires
- Rietja Hart, Bestuurder
- Joris Swennen, Bestuurder
- Anne Bitzer, Bestuurder
- Emmanuel Thiéry, Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Anne Bitzer",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Emmanuel Thi\u00E9ry",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Rietja Hart",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Joris Swennen",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium"
}
}18-01-2021 Publication au Moniteur belge, Divers
Détails techniques
{
"stage": "completed",
"notary": {
"name": "Eric SPRUYT",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2021-01-18",
"filing_date": "2021-01-11",
"act_kind_objet": "VASTSTELLING VAN DE DEFINITIEVE WAARDE VAN HE\u0422"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2020-12-18",
"unanimous": null
},
"conversion": null,
"detected_kind": "demerger_partial",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0406.820.770",
"name": "MSD Belgium",
"role": "demerged",
"address": "Lynx Binnenhof 5, 1200 Brissem",
"is_foreign": false,
"legal_form": "besloten vennootschap",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": null,
"name": "Organon Belgium BV",
"role": "recipient",
"address": null,
"is_foreign": false,
"legal_form": "besloten vennootschap",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"5:121",
"5:133"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2020-10-31",
"exchange_ratio_text": "5.338.747 nieuwe aandelen van elk 1 euro",
"new_shares_issued_n": 5338747,
"real_estate_included": false,
"patrimony_description": "De overgedragen patrimoine bestaat uit de activa en passiva van de Organon Business, inclusief contracten, rechtsverhoudingen en werknemers, zoals omschreven in het partiele splitsingsvoorstel. De waarde van de overdracht is vastgesteld op basis van de balans per 31 oktober 2020.",
"equity_transferred_eur": 5371310.79,
"accounting_effective_date": "2020-11-01"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium",
"legal_form": "besloten vennootschap"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Daisy Dekegel",
"org_rep_person_name": null
},
"summary_narrative": "De buitengewone algemene vergadering van MSD Belgium BV besliste de definitieve waarde van de overgedragen Organon Business-activa en -passiva vast te stellen op basis van de balans per 31 oktober 2020. De waarde bedroeg EUR 5.371.310,79, wat een stijging van EUR 32.563,21 ten opzichte van de oorspronkelijke waardering per 31 december 2019 was. De vergadering besloot de vermindering van het eigen vermogen van MSD Belgium BV aan te passen naar dit bedrag en de overdracht van de activa en passiva naar Organon Belgium BV te bevestigen. De tegenprestatie bestond uit 5.338.747 nieuwe aandelen van O",
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"volmacht"
],
"detected_real_type": "demerger_completed",
"referenced_correction": null,
"should_reroute_to_category": null
}20-11-2020 Modification des statuts
Détails techniques
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium"
},
"legal_form_change": {
"new": "besloten vennootschap",
"old": "besloten vennootschap",
"changed": false
}
}23-09-2020 Publication au Moniteur belge, Divers
Détails techniques
{
"stage": "proposal",
"notary": {
"name": "Jonathan De Landsheere",
"firm_city": null,
"firm_name": null,
"office_city": "Brussel",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2020-09-23",
"filing_date": "2020-09-16",
"act_kind_objet": "Neerlegging en bekendmaking van een voorstel tot parti\u00EBle splitsing"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2020-09-15",
"unanimous": null
},
"conversion": null,
"detected_kind": "demerger_partial",
"report_waiver": {
"summary": "De rapportplichten overeenkomstig artikelen 5:121 en 5:133 van het Wetboek van Vennootschappen en Verenigingen worden geweigerd voor de inbreng in natura.",
"articles": [
"5:121",
"5:133"
]
},
"restructuring": {
"parties": [
{
"kbo": "0406.820.770",
"name": "MSD Belgium BV",
"role": "demerged",
"address": "Lynx Binnenhof 5, 1200 Sint-Lambrechts-Woluwe",
"is_foreign": false,
"legal_form": "Besloten vennootschap",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": "0741.785.526",
"name": "Organon Belgium BV",
"role": "recipient",
"address": "Lynx Binnenhof 5, 1200 Brussel",
"is_foreign": false,
"legal_form": "Besloten vennootschap",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": 0.2064301216197447,
"legal_articles": [
"12:8",
"12:59",
"12:13"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2019-12-31",
"exchange_ratio_text": "0,2064301216197447 aandelen per bestaand aandeel",
"new_shares_issued_n": 5338747,
"real_estate_included": false,
"patrimony_description": "Een deel van het vermogen van MSD Belgium BV, met name de activiteiten van ontwikkeling, commercialisering, distributie en verkoop van de producten zoals opgenomen in Bijlage 1 (de \u0027Producten\u0027), wordt overgedragen aan Organon Belgium BV. Dit omvat de contracten, rechtsverhoudingen en werknemers die daarmee verband houden.",
"equity_transferred_eur": null,
"accounting_effective_date": "2020-11-01"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium",
"legal_form": "Besloten vennootschap"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "ALTIUS CVBA",
"person_name": null,
"org_rep_person_name": "J\u00E9r\u00F4me Vermeylen"
},
"summary_narrative": "De bestuurders van MSD Belgium BV en Organon Belgium BV hebben een voorstel tot partiele splitsing opgesteld overeenkomstig artikel 12:59 van het Wetboek van Vennootschappen en Verenigingen. Het voorstel voorziet in de overdracht van een deel van het vermogen van MSD Belgium BV, met name de Organon Business, naar Organon Belgium BV, zonder dat MSD Belgium BV wordt ontbonden. De overdracht zal juridisch en boekhoudkundig vanaf 1 november 2020 plaatsvinden. De aandeelhouders van MSD Belgium BV zullen aandelen van Organon Belgium BV ontvangen in ruil voor hun aandelen, tegen een ratio van 0,20643",
"co_filed_documents": [
"Voorstel tot een met splitsing gelijkgestelde verrichting opgesteld door de bestuursorganen van MSD Belgium BV (de overdragende vennootschap) en Organon Belgium BV (de overnemende vennootschap) op 15 september 2020",
"Lijst van producten die moeten worden overgedragen aan de Organon Business",
"Lijst van over te dragen activa en passiva",
"Lijst van de over te dragen werknemers",
"Balans van de Organon Business per 31 december 2019",
"Balans van de Overnemende Vennootschap per 20 januari 2020"
],
"detected_real_type": "demerger_proposal",
"referenced_correction": null,
"should_reroute_to_category": null
}26-05-2020 Modification des statuts
Détails techniques
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD BELGIUM"
},
"legal_form_change": {
"new": "",
"old": "besloten vennootschap",
"changed": false
}
}24-10-2019 1 administrateur nommé, 1 démissionnaire
- Anne Bitzer, Zaakvoerder
- Eric Montariol, Zaakvoerder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Eric Montariol",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Anne Bitzer",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium"
}
}09-07-2019 General meeting · Officer reappointment · Board meeting · Officer appointment
- Publication: 09/07/2019
- Filing: 28/06/2019
- General meeting: 27/03/2019
- Officer reappointment: date: 2019-03-27, role: Raad van Bestuur · MSD Belgium N.V.
- Officer reappointment: date: 2019-03-27, role: Raad van Bestuur · Roche N.V.
- Officer reappointment: date: 2019-03-27, role: Raad van Bestuur · Chiesi N.V.
- Officer reappointment: date: 2019-03-27, role: Raad van Bestuur · UCB Pharma N.V.
- Board meeting: 24/04/2019
- Officer appointment: role: ondervoorzitter van de Raad van Bestuur, start_date: 2019-04-24 · Celgene
- Permanent representative · Michel Collard
- Officer resignation: date: 2019-04-24, role: ondervoorzitter van de Raad van Bestuur · MSD Belgium N.V.
- Permanent representative · Clarisse Lhoste
- Officer appointment: role: CEO belast met het dagelijks bestuur · Catherine Rutten
Détails techniques
{
"facts": [
{
"date": "2019-07-09",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 09/07/2019",
"value": "09/07/2019",
"object": null,
"subject": null
},
{
"date": "2019-06-28",
"type": "filing",
"quote": "vangen op 28 JUNI 2019 ter griffie van de Nederlandstalige ondernemingsrechtbank Brusss",
"value": "28/06/2019",
"object": null,
"subject": null
},
{
"date": "2019-03-27",
"type": "general_meeting",
"quote": "ALGEMENE VERGADERING VAN 27 MAART 2019",
"value": "27/03/2019",
"object": null,
"subject": null
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 1. MSD Belgium N.V.",
"value": {
"date": "2019-03-27",
"role": "Raad van Bestuur"
},
"object": null,
"subject": "e1",
"_value_raw": {
"date": "27/03/2019",
"role": "Raad van Bestuur"
}
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 2. Roche N.V.",
"value": {
"date": "2019-03-27",
"role": "Raad van Bestuur"
},
"object": null,
"subject": "e2",
"_value_raw": {
"date": "27/03/2019",
"role": "Raad van Bestuur"
}
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 3. Chiesi N.V.",
"value": {
"date": "2019-03-27",
"role": "Raad van Bestuur"
},
"object": null,
"subject": "e3",
"_value_raw": {
"date": "27/03/2019",
"role": "Raad van Bestuur"
}
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 4. UCB Pharma N.V.",
"value": {
"date": "2019-03-27",
"role": "Raad van Bestuur"
},
"object": null,
"subject": "e4",
"_value_raw": {
"date": "27/03/2019",
"role": "Raad van Bestuur"
}
},
{
"date": "2019-04-24",
"type": "board_meeting",
"quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 24 APRIL 2019",
"value": "24/04/2019",
"object": null,
"subject": null
},
{
"date": "2019-04-24",
"type": "officer_appointment",
"quote": "Op de Raad van Bestuur van 24 april 2019 werd Celgene, vertegenwoordigd door Michel Collard, verkozen tot nieuwe ondervoorzitter van de Raad van Bestuur",
"value": {
"role": "ondervoorzitter van de Raad van Bestuur",
"start_date": "2019-04-24"
},
"object": null,
"subject": "e5",
"_value_raw": {
"role": "ondervoorzitter van de Raad van Bestuur",
"start_date": "24/04/2019"
}
},
{
"type": "permanent_representative",
"quote": "Celgene, vertegenwoordigd door Michel Collard",
"value": null,
"object": "e5",
"subject": "e6"
},
{
"date": "2019-04-24",
"type": "officer_resignation",
"quote": "in opvolging van MSD Belgium, vertegenwoordigd door Clarisse Lhoste",
"value": {
"date": "2019-04-24",
"role": "ondervoorzitter van de Raad van Bestuur"
},
"object": null,
"subject": "e1",
"_value_raw": {
"date": "24/04/2019",
"role": "ondervoorzitter van de Raad van Bestuur"
}
},
{
"type": "permanent_representative",
"quote": "MSD Belgium, vertegenwoordigd door Clarisse Lhoste",
"value": null,
"object": "e1",
"subject": "e7"
},
{
"type": "officer_appointment",
"quote": "Catherine Rutten CEO belast met het dagelijks bestuur",
"value": {
"role": "CEO belast met het dagelijks bestuur"
},
"object": null,
"subject": "e8"
}
],
"act_meta": {
"outcome": "corrected",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1672,
"truncated": false
},
"entities": [
{
"id": "e0",
"kbo": "0407.622.902",
"kind": "company",
"name": "Algemene Vereniging van de Geneesmiddelenindustrie",
"attrs": {
"seat": "Terhulpsesteenweg 166, 1170 BRUSSEL",
"legal_form": "Vereniging zonder winstoogmerk",
"short_name": "AVGI"
}
},
{
"id": "e1",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD Belgium N.V.",
"attrs": {
"seat": "Lynx Binnenhof 5, 1200 Sint-Lambrechts-Woluwe"
}
},
{
"id": "e2",
"kbo": "0403.088.151",
"kind": "company",
"name": "Roche N.V.",
"attrs": {
"seat": "Dantestraat 75, 1070 Anderlecht"
}
},
{
"id": "e3",
"kbo": "0826.654.883",
"kind": "company",
"name": "Chiesi N.V.",
"attrs": {
"seat": "Telecomlaan 9, 1831 Diegem"
}
},
{
"id": "e4",
"kbo": "0403.096.168",
"kind": "company",
"name": "UCB Pharma N.V.",
"attrs": {
"seat": "Researchdreef 60, 1070 Anderlecht"
}
},
{
"id": "e5",
"kbo": null,
"kind": "company",
"name": "Celgene",
"attrs": {}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Michel Collard",
"attrs": {}
},
{
"id": "e7",
"kbo": null,
"kind": "person",
"name": "Clarisse Lhoste",
"attrs": {}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "Catherine Rutten",
"attrs": {}
}
]
}09-07-2019 General meeting · Officer reappointment · Board meeting · Officer appointment
- Publication: 2019
- Filing: 28/05/2019
- General meeting: 27/03/2019
- Officer reappointment: date: 2019-03-27, role: Membre du Conseil d'administration · MSD Belgium S.A.
- Officer reappointment: date: 2019-03-27, role: Membre du Conseil d'administration · Roche S.A.
- Officer reappointment: date: 2019-03-27, role: Membre du Conseil d'administration · Chiesi S.A.
- Officer reappointment: date: 2019-03-27, role: Membre du Conseil d'administration · UCB Belgium S.A.
- Board meeting: 24/04/2019
- Officer appointment: role: Vice-Président du Conseil d'administration, start_date: 2019-04-24 · Celgene
- Permanent representative · Michel Collard
- Permanent representative · Clarisse Lhoste
Détails techniques
{
"facts": [
{
"date": "2019-07-09",
"type": "publication",
"quote": "2019 - Annexes du Moniteur belge",
"value": "2019",
"object": null,
"subject": null
},
{
"date": "2019-05-28",
"type": "filing",
"quote": "neergelegd/ontvangen op 28 JUMM 2019",
"value": "28/05/2019",
"object": null,
"subject": null
},
{
"date": "2019-03-27",
"type": "general_meeting",
"quote": "ASSEMBLEE GENERALE DU 27 MARS 2019",
"value": "27/03/2019",
"object": null,
"subject": null
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 1. MSD Belgium S.A.",
"value": {
"date": "2019-03-27",
"role": "Membre du Conseil d\u0027administration"
},
"object": null,
"subject": "e1",
"_value_raw": {
"date": "27/03/2019",
"role": "Membre du Conseil d\u0027administration"
}
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 2. Roche S.A.",
"value": {
"date": "2019-03-27",
"role": "Membre du Conseil d\u0027administration"
},
"object": null,
"subject": "e2",
"_value_raw": {
"date": "27/03/2019",
"role": "Membre du Conseil d\u0027administration"
}
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 3. Chiesi S.A.",
"value": {
"date": "2019-03-27",
"role": "Membre du Conseil d\u0027administration"
},
"object": null,
"subject": "e3",
"_value_raw": {
"date": "27/03/2019",
"role": "Membre du Conseil d\u0027administration"
}
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 4. UCB Belgium S.A.",
"value": {
"date": "2019-03-27",
"role": "Membre du Conseil d\u0027administration"
},
"object": null,
"subject": "e4",
"_value_raw": {
"date": "27/03/2019",
"role": "Membre du Conseil d\u0027administration"
}
},
{
"date": "2019-04-24",
"type": "board_meeting",
"quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 24 AVRIL 2019",
"value": "24/04/2019",
"object": null,
"subject": null
},
{
"date": "2019-04-24",
"type": "officer_appointment",
"quote": "Celgene ... a \u00E9t\u00E9 \u00E9lue nouveau Vice-Pr\u00E9sident du Conseil d\u0027administration",
"value": {
"role": "Vice-Pr\u00E9sident du Conseil d\u0027administration",
"start_date": "2019-04-24"
},
"object": null,
"subject": "e5",
"_value_raw": {
"role": "Vice-Pr\u00E9sident du Conseil d\u0027administration",
"start_date": "24/04/2019"
}
},
{
"type": "permanent_representative",
"quote": "Celgene, repr\u00E9sent\u00E9e par Michel Collard",
"value": null,
"object": "e5",
"subject": "e6"
},
{
"type": "permanent_representative",
"quote": "MSD Belgium, repr\u00E9sent\u00E9e par Clarisse Lhoste",
"value": null,
"object": "e1",
"subject": "e7"
}
],
"act_meta": {
"outcome": "corrected",
"postfix": [
"publication date None -\u003E edition 2019-07-09"
],
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1695,
"truncated": false
},
"entities": [
{
"id": "e0",
"kbo": "0407.622.902",
"kind": "company",
"name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
"attrs": {
"seat": "chauss\u00E9e de La Hulpe 166, 1170 BRUXELLES",
"legal_form": "Association sans But Lucratif",
"short_name": "AGIM"
}
},
{
"id": "e1",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD Belgium S.A.",
"attrs": {
"seat": "Clos du Lynx 5, 1200 Woluwe-Saint-Lambert"
}
},
{
"id": "e2",
"kbo": "0403.088.151",
"kind": "company",
"name": "Roche S.A.",
"attrs": {
"seat": "rue Dante 75, 1070 Anderlecht"
}
},
{
"id": "e3",
"kbo": "0826.654.883",
"kind": "company",
"name": "Chiesi S.A.",
"attrs": {
"seat": "Telecomlaan 9, 1831 Diegem"
}
},
{
"id": "e4",
"kbo": "0403.096.168",
"kind": "company",
"name": "UCB Belgium S.A.",
"attrs": {
"seat": "All\u00E9e de la Recherche 60, 1070 Anderlecht"
}
},
{
"id": "e5",
"kbo": null,
"kind": "company",
"name": "Celgene",
"attrs": {}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Michel Collard",
"attrs": {}
},
{
"id": "e7",
"kbo": null,
"kind": "person",
"name": "Clarisse Lhoste",
"attrs": {}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "Catherine Rutten",
"attrs": {}
}
]
}20-03-2019 1 administrateur nommé, 1 démissionnaire
- Brecht Vanneste, Zaakvoerder
- Clarisse Jacob Lhoste, Zaakvoerder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Clarisse Jacob Lhoste",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Brecht Vanneste",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD BELGIUM"
}
}23-01-2019 2 administrateurs nommés, 2 démissionnaires
- PWC Bedrijfsrevisoren BV CVBA, Commissaris
- Didier Delanoye, Commissaris
- PWC Bedrijfsrevisoren BV CVBA, Commissaris
- Didier Delanoye, Commissaris
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "PWC Bedrijfsrevisoren BV CVBA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Didier Delanoye",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "PWC Bedrijfsrevisoren BV CVBA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Didier Delanoye",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD BELGIUM"
}
}11-10-2017 1 administrateur nommé, 1 démissionnaire
- Tine Van den Haute, Zaakvoerder
- Chris Foreman, Zaakvoerder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Chris Foreman",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Tine Van den Haute",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD BELGIUM"
}
}22-08-2017 Opération sur le capital ou les actions
Détails techniques
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium"
}
}14-06-2017 Publication au Moniteur belge, Divers
Détails techniques
{
"stage": "proposal",
"notary": {
"name": "Esther Goldschmidt",
"firm_city": null,
"firm_name": null,
"office_city": "Brussel",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2017-06-14",
"filing_date": "2017-06-02",
"act_kind_objet": "Neerlegging fusievoorstel"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2017-06-02",
"unanimous": null
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0406.820.770",
"name": "MSD BELGIUM",
"role": "acquiring",
"address": "Lynx Binnenhof 5, 1200 Sint-Lambrechts-Woluwe",
"is_foreign": false,
"legal_form": "BVBA",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": "0402.506.646",
"name": "MSD VACCINES BELGIUM",
"role": "absorbed",
"address": "Leonardo Da Vincilaan 19, 1831 Diegem",
"is_foreign": false,
"legal_form": "NV",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [
"12:7",
"12:50",
"12:75",
"12:103"
],
"is_cross_border": false,
"is_silent_merger": true,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "Het volledige vermogen van MSD Vaccines Belgium NV, inclusief actief, passief, rechten en verplichtingen, wordt overgenomen door MSD Belgium BVBA.",
"equity_transferred_eur": null,
"accounting_effective_date": "2017-01-01"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD BELGIUM",
"legal_form": "BVBA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Esther Goldschmidt",
"org_rep_person_name": null
},
"summary_narrative": "Op 2 juni 2017 werd een voorstel tot fusie door overneming gepubliceerd tussen MSD Belgium BVBA (overnemende vennootschap) en MSD Vaccines Belgium NV (over te nemen vennootschap). De fusie is van toepassing op artikel 693 en volgende van het Wetboek van Vennootschappen en is een vereenvoudigde fusie, aangezien MSD Belgium al alle aandelen van MSD Vaccines bezit. De fusie zal boekhoudkundig gelden vanaf 1 januari 2017.",
"co_filed_documents": [
"fusievoorstel van 2 juni 2017"
],
"detected_real_type": "fusion_proposal",
"referenced_correction": null,
"should_reroute_to_category": null
}24-10-2016 1 administrateur nommé, 1 démissionnaire
- Clarisse Jacob Lhoste, Zaakvoerder
- Patricia Massetti, Zaakvoerder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Patricia Massetti",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Clarisse Jacob Lhoste",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD BELGIUM"
}
}20-06-2016 Didier Delanoye nommé vaste vertegenwoordiger van de commissaris
- Didier Delanoye, Vaste vertegenwoordiger van de commissaris
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "vaste vertegenwoordiger van de commissaris",
"person": {
"rrn": null,
"name": "Didier Delanoye",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD BELGIUM"
}
}11-05-2016 General meeting · Officer appointment · Officer reappointment · Officer resignation
- Publication: 11/05/2016 · Association Générale de l'Industrie du Médicament
- Filing: 29/04/2016 · Association Générale de l'Industrie du Médicament
- General meeting: 18/03/2016 · Association Générale de l'Industrie du Médicament
- Officer appointment: role: administrateur, start_date: 2016-03-18 · Roche S.A.
- Officer appointment: role: administrateur, start_date: 2016-03-18 · Chiesi S.A.
- Officer reappointment: role: administrateur, start_date: 2016-03-18 · MSD Belgium S.A.
- Officer reappointment: role: administrateur, start_date: 2016-03-18 · UCB Belgium S.A.
- Officer resignation: date: 2016-03-18, role: administrateur · AstraZeneca S.A.
- Officer resignation: date: 2016-03-18, role: administrateur · Baxter Belgium SPRL
- Officer resignation: date: 2016-03-18, role: administrateur · Bracco Imaging Europe B.V.
- Statute amendment: article: 14, description: Poids des votes, procuration et procédure de vote · Association Générale de l'Industrie du Médicament
- Statute amendment: article: 16, description: Composition du Conseil d'administration · Association Générale de l'Industrie du Médicament
- Statute amendment: article: 21, description: Mandats · Association Générale de l'Industrie du Médicament
- Statute amendment: article: 27ter, description: Organes (groupe pharma.be animal health) · Association Générale de l'Industrie du Médicament
- Statute amendment: article: 33, description: Conditions d'admission et durée de mandat exceptionnelle · Association Générale de l'Industrie du Médicament
Détails techniques
{
"facts": [
{
"date": "2016-05-11",
"type": "publication",
"quote": "Bijlagen bij het Belgisch. Staatshlad -11/05/2016-",
"value": "11/05/2016",
"object": null,
"subject": "e1"
},
{
"date": "2016-04-29",
"type": "filing",
"quote": "neergelegd/entvangen op 29 APR, 2016",
"value": "29/04/2016",
"object": null,
"subject": "e1"
},
{
"date": "2016-03-18",
"type": "general_meeting",
"quote": "ASSEMBLEE GENERALE DU 18 MARS 2016",
"value": "18/03/2016",
"object": null,
"subject": "e1"
},
{
"date": "2016-03-18",
"type": "officer_appointment",
"quote": "Nomination de: 1. Roche S.A.",
"value": {
"role": "administrateur",
"start_date": "2016-03-18"
},
"object": "e1",
"subject": "e2",
"_value_raw": {
"role": "administrateur",
"start_date": "18/03/2016"
}
},
{
"date": "2016-03-18",
"type": "officer_appointment",
"quote": "Nomination de: 2. Chiesi S.A.",
"value": {
"role": "administrateur",
"start_date": "2016-03-18"
},
"object": "e1",
"subject": "e3",
"_value_raw": {
"role": "administrateur",
"start_date": "18/03/2016"
}
},
{
"date": "2016-03-18",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 1. MSD Belgium S.A.",
"value": {
"role": "administrateur",
"start_date": "2016-03-18"
},
"object": "e1",
"subject": "e4",
"_value_raw": {
"role": "administrateur",
"start_date": "18/03/2016"
}
},
{
"date": "2016-03-18",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 2. UCB Belgium S.A.",
"value": {
"role": "administrateur",
"start_date": "2016-03-18"
},
"object": "e1",
"subject": "e5",
"_value_raw": {
"role": "administrateur",
"start_date": "18/03/2016"
}
},
{
"date": "2016-03-18",
"type": "officer_resignation",
"quote": "D\u00E9mission de : 1. AstraZeneca S.A.",
"value": {
"date": "2016-03-18",
"role": "administrateur"
},
"object": "e1",
"subject": "e6",
"_value_raw": {
"date": "18/03/2016",
"role": "administrateur"
}
},
{
"date": "2016-03-18",
"type": "officer_resignation",
"quote": "D\u00E9mission de : 2. Baxter Belgium SPRL",
"value": {
"date": "2016-03-18",
"role": "administrateur"
},
"object": "e1",
"subject": "e7",
"_value_raw": {
"date": "18/03/2016",
"role": "administrateur"
}
},
{
"date": "2016-03-18",
"type": "officer_resignation",
"quote": "D\u00E9mission de : 3. Bracco Imaging Europe B.V.",
"value": {
"date": "2016-03-18",
"role": "administrateur"
},
"object": "e1",
"subject": "e8",
"_value_raw": {
"date": "18/03/2016",
"role": "administrateur"
}
},
{
"type": "statute_amendment",
"quote": "article 14. Poids des votes, procuration et proc\u00E9dure de vote",
"value": {
"article": "14",
"description": "Poids des votes, procuration et proc\u00E9dure de vote"
},
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "article 16. Composition",
"value": {
"article": "16",
"description": "Composition du Conseil d\u0027administration"
},
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "article 21. Mandats",
"value": {
"article": "21",
"description": "Mandats"
},
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "Article 27ter. Organes",
"value": {
"article": "27ter",
"description": "Organes (groupe pharma.be animal health)"
},
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "article 33.",
"value": {
"article": "33",
"description": "Conditions d\u0027admission et dur\u00E9e de mandat exceptionnelle"
},
"object": null,
"subject": "e1"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 16790,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0407.622.902",
"kind": "company",
"name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
"attrs": {
"seat": "chauss\u00E9e de La Hulpe 166, 1170 BRUXELLES",
"legal_form": "Association sans But Lucratif",
"short_name": "AGIM"
}
},
{
"id": "e2",
"kbo": "0403.088.151",
"kind": "company",
"name": "Roche S.A.",
"attrs": {
"seat": "rue Dante 75, 1070 Anderlecht"
}
},
{
"id": "e3",
"kbo": "0826.654.883",
"kind": "company",
"name": "Chiesi S.A.",
"attrs": {
"seat": "avenue du Bourget 44, 1130 Haren (Bruxelles)"
}
},
{
"id": "e4",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD Belgium S.A.",
"attrs": {
"seat": "Clos du Lynx 5, 1200 Woluwe-Saint-Lambert"
}
},
{
"id": "e5",
"kbo": "0403.096.168",
"kind": "company",
"name": "UCB Belgium S.A.",
"attrs": {
"seat": "All\u00E9e de la Recherche 60, 1070 Anderlecht"
}
},
{
"id": "e6",
"kbo": "0400.165.679",
"kind": "company",
"name": "AstraZeneca S.A.",
"attrs": {
"seat": "rue Egide Van Ophem 110, 1180 Uccle"
}
},
{
"id": "e7",
"kbo": "0861.155.805",
"kind": "company",
"name": "Baxter Belgium SPRL",
"attrs": {
"seat": "boulevard d\u0027Angleterre 2-4, 1420 Braine l\u0027Alleud"
}
},
{
"id": "e8",
"kbo": "0892.349.322",
"kind": "company",
"name": "Bracco Imaging Europe B.V.",
"attrs": {
"seat": "avenue Pasteur 6, 1300 Wavre"
}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "Catherine Rutten",
"attrs": {
"role": "CEO charg\u00E9 de la gestion journali\u00E8re"
}
}
]
}04-12-2015 4 administrateurs nommés, 1 démissionnaire
- Jérôme Vermeylen, Volmacht
- Esther Goldschmidt, Volmacht
- Alexandra Sansen, Volmacht
- Kirian Claeyé, Volmacht
- Alette Verbeek, Volmacht
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "volmacht",
"person": {
"rrn": null,
"name": "Alette Verbeek",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "volmacht",
"person": {
"rrn": null,
"name": "J\u00E9r\u00F4me Vermeylen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "volmacht",
"person": {
"rrn": null,
"name": "Esther Goldschmidt",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "volmacht",
"person": {
"rrn": null,
"name": "Alexandra Sansen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "volmacht",
"person": {
"rrn": null,
"name": "Kirian Claey\u00E9",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD BELGIUM"
}
}22-07-2015 2 administrateurs nommés
- PwC Bedrijfsrevisoren, Commissaris
- Jan De Laet, Vertegenwoordiger commissaris
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "PwC Bedrijfsrevisoren",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vertegenwoordiger commissaris",
"person": {
"rrn": null,
"name": "Jan De Laet",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD BELGIUM"
}
}09-12-2014 Board meeting · Power of attorney · Filing representative
- Publication: 09/12/2014 · MSD BELGIUM
- Filing: 28/11/2014 · MSD BELGIUM
- Board meeting: 06/11/2014 · MSD BELGIUM
- Power of attorney: scope: Toekenning van bijzondere volmachten aan personen met specifieke titels (Market Access Head, Medical Director, etc.) voor het ondertekenen van specifieke overeenkomsten (sprekers, adviesraden, arbeidsovereenkomsten, sponsoring, confidentialiteit, klinische testen). Vervanging van de regeling van 13 december 2012. · MSD BELGIUM
- Filing representative: scope: Vervulling van de formaliteiten voor de neerlegging en publicatie van het besluit tot toekenning van een volmacht · ALTIUS
Détails techniques
{
"facts": [
{
"date": "2014-12-09",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 09/12/2014",
"value": "09/12/2014",
"object": null,
"subject": "e1"
},
{
"date": "2014-11-28",
"type": "filing",
"quote": "neergelegd/entvangen op 28 NOV. 2014",
"value": "28/11/2014",
"object": null,
"subject": "e1"
},
{
"date": "2014-11-06",
"type": "board_meeting",
"quote": "Uittreksel uit de eenparige schriftelijke besluiten van de zaakvoerders genomen op 6 november 2014",
"value": "06/11/2014",
"object": null,
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "De zaakvoerders besluiten om de personen die, van tijd tot tijd, binnen de Vennootschap de titels dragen die hierna vermeld worden (de \u0022Gevolmachtigden\u0022), met onmiddellijke ingang te benoemen als rechtsgeldige gevolmachtigden van de Vennootschap... De zaakvoerders besluiten om de volgende bijzondere volmachten te verlenen...",
"value": {
"scope": "Toekenning van bijzondere volmachten aan personen met specifieke titels (Market Access Head, Medical Director, etc.) voor het ondertekenen van specifieke overeenkomsten (sprekers, adviesraden, arbeidsovereenkomsten, sponsoring, confidentialiteit, klinische testen). Vervanging van de regeling van 13 december 2012."
},
"object": null,
"subject": "e1"
},
{
"type": "filing_representative",
"quote": "De zaakvoerders besluiten een bijzondere volmacht te verlenen aan J\u00E9r\u00F4me Vermeylen, Kurt Grillet, Alexandra Sansen en Esther Goldschmidt, en enige andere advocaat van het advocatenkantoor ALTIUS... bevoegd om... de Vennootschap te vertegenwoordigen met het oog op de vervulling van de formaliteiten voor de neerlegging en publicatie vna het bovenstaande besluit",
"value": {
"scope": "Vervulling van de formaliteiten voor de neerlegging en publicatie van het besluit tot toekenning van een volmacht"
},
"object": "e1",
"subject": "e6"
}
],
"act_meta": {
"outcome": "review",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 4554,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD BELGIUM",
"attrs": {
"seat": "Lynx Binnenhof 5, 1200 Brussel, Belgi\u00EB",
"legal_form": "Besloten vennootschap met beperkte aansprakelijkheid"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "J\u00E9r\u00F4me Vermeylen",
"attrs": {}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Kurt Grillet",
"attrs": {}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Alexandra Sansen",
"attrs": {}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Esther Goldschmidt",
"attrs": {}
},
{
"id": "e6",
"kbo": null,
"kind": "org",
"name": "ALTIUS",
"attrs": {
"address": "Havenlaan 86 C B.414, 1000 Brussel"
}
}
]
}03-06-2013 Act object · General meeting · Officer appointment · Filing representative
- Act object: Benoeming van een zaakvoerder · MSD BELGIUM
- Publication: 03/06/2013 · MSD BELGIUM
- Filing: 23/05/2013 · MSD BELGIUM
- General meeting: 27/03/2013 · MSD BELGIUM
- Officer appointment: role: zaakvoerder, term: onbepaalde duur, start_date: 2013-04-01 · Patricia Massetti
- Filing representative: bijzondere volmacht, met mogelijkheid van indeplaatsstelling ... voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen · Altius CVBA
- Filing representative: bijzondere volmacht, met mogelijkheid van indeplaatsstelling ... voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen · Jérôme Vermeylen
- Filing representative: bijzondere volmacht, met mogelijkheid van indeplaatsstelling ... voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen · Kathelijne Beckers
- Filing representative: bijzondere volmacht, met mogelijkheid van indeplaatsstelling ... voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen · Esther Goldschmidt
Détails techniques
{
"facts": [
{
"type": "act_object",
"quote": "Onderwerp akte: Benoeming van een zaakvoerder",
"value": "Benoeming van een zaakvoerder",
"object": null,
"subject": "e1"
},
{
"date": "2013-06-03",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 03/06/2013",
"value": "03/06/2013",
"object": null,
"subject": "e1"
},
{
"date": "2013-05-23",
"type": "filing",
"quote": "23 M 2013",
"value": "23/05/2013",
"object": null,
"subject": "e1"
},
{
"date": "2013-03-27",
"type": "general_meeting",
"quote": "Uittreksel uit de eenparige schriftelijke besluiten van de vennoten van 27 maart 2013",
"value": "27/03/2013",
"object": null,
"subject": "e1"
},
{
"date": "2013-04-01",
"type": "officer_appointment",
"quote": "De vennoten besluiten mevrouw Patricia Massetti ... met ingang per 1 april 2013 en voor onbepaalde duur als zaakvoerder van de Vennootschap te benoemen.",
"value": {
"role": "zaakvoerder",
"term": "onbepaalde duur",
"start_date": "2013-04-01"
},
"object": "e1",
"subject": "e2",
"_value_raw": {
"role": "zaakvoerder",
"term": "onbepaalde duur",
"start_date": "01/04/2013"
}
},
{
"type": "filing_representative",
"quote": "De vennoten besluiten een bijzondere volmacht, met mogelijkheid van indeplaatsstelling, toe te kennen aan J\u00E9r\u00F4me Vermeylen, Kathelijne Beckers en Esther Goldschmidt en aan iedere andere advocaat van het kantoor Altius CVBA ... bevoegd om afzonderlijk te handelen en om de Vennootschap te vertegenwoordigen voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen",
"value": "bijzondere volmacht, met mogelijkheid van indeplaatsstelling ... voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen",
"object": "e1",
"subject": "e3"
},
{
"type": "filing_representative",
"quote": "De vennoten besluiten een bijzondere volmacht, met mogelijkheid van indeplaatsstelling, toe te kennen aan J\u00E9r\u00F4me Vermeylen, Kathelijne Beckers en Esther Goldschmidt en aan iedere andere advocaat van het kantoor Altius CVBA ... bevoegd om afzonderlijk te handelen en om de Vennootschap te vertegenwoordigen voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen",
"value": "bijzondere volmacht, met mogelijkheid van indeplaatsstelling ... voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen",
"object": "e1",
"subject": "e4"
},
{
"type": "filing_representative",
"quote": "De vennoten besluiten een bijzondere volmacht, met mogelijkheid van indeplaatsstelling, toe te kennen aan J\u00E9r\u00F4me Vermeylen, Kathelijne Beckers en Esther Goldschmidt en aan iedere andere advocaat van het kantoor Altius CVBA ... bevoegd om afzonderlijk te handelen en om de Vennootschap te vertegenwoordigen voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen",
"value": "bijzondere volmacht, met mogelijkheid van indeplaatsstelling ... voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen",
"object": "e1",
"subject": "e5"
},
{
"type": "filing_representative",
"quote": "De vennoten besluiten een bijzondere volmacht, met mogelijkheid van indeplaatsstelling, toe te kennen aan J\u00E9r\u00F4me Vermeylen, Kathelijne Beckers en Esther Goldschmidt en aan iedere andere advocaat van het kantoor Altius CVBA ... bevoegd om afzonderlijk te handelen en om de Vennootschap te vertegenwoordigen voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen",
"value": "bijzondere volmacht, met mogelijkheid van indeplaatsstelling ... voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen",
"object": "e1",
"subject": "e6"
}
],
"act_meta": {
"outcome": "corrected",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1823,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD BELGIUM",
"attrs": {
"seat": "Lynx Binnenhof 5, 1200 Brussel, Belgi\u00EB",
"legal_form": "Besloten vennootschap met beperkte aansprakelijkheid"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Patricia Massetti",
"attrs": {
"address": "B-1200 Brussel, Lynx Binnenhof 5"
}
},
{
"id": "e3",
"kbo": null,
"kind": "org",
"name": "Altius CVBA",
"attrs": {
"address": "Havenlaan 86C B.414, B-1000 Brussel"
}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "J\u00E9r\u00F4me Vermeylen",
"attrs": {}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Kathelijne Beckers",
"attrs": {}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Esther Goldschmidt",
"attrs": {}
}
]
}Générez une note structurée et factuelle à partir de tous les signaux de ce dossier : risque, santé financière, structure de propriété, mandats et comparaison sectorielle.
| Dénomination légaleNL | MSD BELGIUM |